Skip to main content
# Title Department Research Year
341 Latanoprost niosomes as a sustained release ocular delivery system for the
management of glaucoma
Department of Pharmaceutics 2020
342 Synthesis of some new 1,2-disubstituted-1,2,4-triazolobenzimidazoles with antifungal and anti-inflammatory effects. Department of Pharmaceutical Organic Chemistry 2020
343 Enzyme-free and label-free strategy for electrochemical oxaliplatin aptasensing by using rGO/MWCNTs loaded with AuPd nanoparticles as signal probes and electro-catalytic enhancers Department of Pharmaceutical Analytical Chemistry 2020
344 Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19 Department of Pharmaceutics 2020
345 Design and synthesis of some 1,3,5-tri-substituted oxindole derivatives as potential CDK inhibitors Department of Medicinal Chemistry 2020
346 Antimicrobial Pyridazines: Synthesis, Characterization, Cytotoxicity, Substrate Promiscuity, and Molecular Docking Department of Pharmaceutical Organic Chemistry 2020
347 Severe cutaneous adverse drug reactions: Incidence, Clinical Patterns, Causative Drugs and Modalities of Treatment in Assiut University Hospital, Upper Egypt 2020
348 Novel Sponge-Like Mn5O8 Nanoparticles Deposited on Graphite Electrode for Electrochemical Study of Hepatitis C Antiviral Drug, Elbasvir 2020
349 Epigallocatechin-3-Gallate-Loaded Gold
Nanoparticles: Preparation and Evaluation of
Anticancer Efficacy in Ehrlich Tumor-Bearing Mice
Department of Pharmaceutics 2020
350 Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation Department of Pharmaceutical Organic Chemistry 2020